CDMP1/GDF5 has specific processing requirements that restrict its action to joint surfaces.

J Biol Chem

Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Bethesda, Maryland 20892, USA.

Published: September 2006

CDMP1/GDF5 has not demonstrated biological activity in Xenopus embryos when overexpressed by mRNA injection. We provide biological and biochemical evidence that to become active, the protein requires cleavage by two distinct proteolytic enzymes. We demonstrate a specific overlap in the expression patterns of CDMP1/GDF5 with the proteases required to release the mature peptide at the location of the future articular surface but not in the future joint space. Taken together, these observations provide a plausible mechanism for local action of CDMP1/GDF5 consistent with requirements imposed by current models of pattern formation in the developing limb.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M603851200DOI Listing

Publication Analysis

Top Keywords

cdmp1/gdf5
4
cdmp1/gdf5 specific
4
specific processing
4
processing requirements
4
requirements restrict
4
restrict action
4
action joint
4
joint surfaces
4
surfaces cdmp1/gdf5
4
cdmp1/gdf5 demonstrated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!